These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25476751)

  • 1. Inhibition of hepatitis E virus replication by proteasome inhibitor is nonspecific.
    Xu L; Zhou X; Peppelenbosch MP; Pan Q
    Arch Virol; 2015 Feb; 160(2):435-9. PubMed ID: 25476751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
    Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
    Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct Antiviral Potency of Sofosbuvir Against Hepatitis C and E Viruses.
    Wang W; Hakim MS; Nair VP; de Ruiter PE; Huang F; Sprengers D; Van Der Laan LJ; Peppelenbosch MP; Surjit M; Pan Q
    Gastroenterology; 2016 Dec; 151(6):1251-1253. PubMed ID: 27815000
    [No Abstract]   [Full Text] [Related]  

  • 4. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
    Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
    Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
    Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
    Kaushik N; Anang S; Ganti KP; Surjit M
    DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zinc mesoporphyrin induces rapid proteasomal degradation of hepatitis C nonstructural 5A protein in human hepatoma cells.
    Hou W; Tian Q; Zheng J; Bonkovsky HL
    Gastroenterology; 2010 May; 138(5):1909-19. PubMed ID: 19909748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for hepatitis C virus with heat-shock protein 90 inhibitor 17-AAG and proteasome inhibitor MG132.
    Ujino S; Yamaguchi S; Shimotohno K; Takaku H
    Antivir Chem Chemother; 2010 Mar; 20(4):161-7. PubMed ID: 20231781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutthroat trout virus as a surrogate in vitro infection model for testing inhibitors of hepatitis E virus replication.
    Debing Y; Winton J; Neyts J; Dallmeier K
    Antiviral Res; 2013 Oct; 100(1):98-101. PubMed ID: 23916729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
    Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
    Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ethanol extract of Lysimachia mauritiana exhibits inhibitory activity against hepatitis E virus genotype 3 replication.
    Jin SE; Kim JE; Kim SY; Park BJ; Song YJ
    J Microbiol; 2017 Dec; 55(12):984-988. PubMed ID: 29214492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rat model for hepatitis E virus.
    Debing Y; Mishra N; Verbeken E; Ramaekers K; Dallmeier K; Neyts J
    Dis Model Mech; 2016 Oct; 9(10):1203-1210. PubMed ID: 27483350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective inhibition of hepatitis E virus replication in A549 cells and piglets by RNA interference (RNAi) targeting RNA-dependent RNA polymerase.
    Huang F; Hua X; Yang S; Yuan C; Zhang W
    Antiviral Res; 2009 Sep; 83(3):274-81. PubMed ID: 19576249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological or pharmacological activation of protein kinase C alpha constrains hepatitis E virus replication.
    Wang W; Wang Y; Debing Y; Zhou X; Yin Y; Xu L; Herrera Carrillo E; Brandsma JH; Poot RA; Berkhout B; Neyts J; Peppelenbosch MP; Pan Q
    Antiviral Res; 2017 Apr; 140():1-12. PubMed ID: 28077314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of GBF1 as a cellular factor required for hepatitis E virus RNA replication.
    Farhat R; Ankavay M; Lebsir N; Gouttenoire J; Jackson CL; Wychowski C; Moradpour D; Dubuisson J; Rouillé Y; Cocquerel L
    Cell Microbiol; 2018 Jan; 20(1):. PubMed ID: 29112323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
    Nishiyama T; Kobayashi T; Jirintai S; Nagashima S; Primadharsini PP; Nishizawa T; Okamoto H
    Antiviral Res; 2019 Oct; 170():104570. PubMed ID: 31362004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasome inhibitors: a novel tool to suppress human cytomegalovirus replication and virus-induced immune modulation.
    Prösch S; Priemer C; Höflich C; Liebenthaf C; Babel N; Krüger DH; Volk HD
    Antivir Ther; 2003 Dec; 8(6):555-67. PubMed ID: 14760889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
    Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral Candidates for Treating Hepatitis E Virus Infection.
    Netzler NE; Enosi Tuipulotu D; Vasudevan SG; Mackenzie JM; White PA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin.
    Dao Thi VL; Debing Y; Wu X; Rice CM; Neyts J; Moradpour D; Gouttenoire J
    Gastroenterology; 2016 Jan; 150(1):82-85.e4. PubMed ID: 26408347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.